Company Directories & Business Directories
JOURNAL LE REVEIL
Company Name: Corporate Name:
JOURNAL LE REVEIL
Company Title:
Company Description:
Keywords to Search:
Company Address:
3388 Boul Saint-Francois,JONQUIERE,QC,Canada
ZIP Code: Postal Code:
G7X2W9
Telephone Number:
4186952601
Fax Number:
4186951391
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):
271101
USA SIC Description:
Newspapers (Publishers)
Number of Employees:
100 to 249
Sales Amount:
$10 to 20 million
Credit History:
Credit Report:
Excellent
Contact Person:
Diane Audet
Remove my name
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example , Blogger Example )
copy to clipboard
Company News:
The New England Journal of Medicine | Research Review Articles on . . . The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer In a phase 3, open-label trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer that recurred or progressed during or after
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP
Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans Highly pathogenic avian influenza A(H5N1) viruses have caused widespread infections in dairy cows and poultry in the United States, with sporadic human cases We describe characteristics of human A
Medical Management and Revascularization for Asymptomatic Carotid . . . Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis Whether adding revascularization t
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis In a phase 3, randomized, controlled trial, we assigned adults with biopsy-proven active lupus nephritis in a 1:1 ratio to receive obinutuzumab in one of two dose schedules (1000 mg on day 1 and
Lorundrostat Efficacy and Safety in Patients with Uncontrolled . . . Aldosterone dysregulation contributes to hypertension Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual Current disease-modifying therapies for multiple sclero